| Trial ID: | L1949 |
| Source ID: | NCT00290394
|
| Associated Drug: |
Rosiglitazone(Drug), Blood Pressure Lowering Effect
|
| Title: |
Ambulatory Blood Pressure Reduction After Rosiglitazone Treatment In Normotensive Type 2 Diabetic Patients
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: rosiglitazone(drug), blood pressure lowering effect
|
| Outcome Measures: |
Primary: Ambulatory blood pressure monitors used to determine the subjects blood pressure before and after the treatment. At the end of three months period wit rosiglitazone treatment diastolic blood pressure decreased. |
|
| Sponsor/Collaborators: |
Sponsor: Baskent University
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
25
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2004-03
|
| Completion Date: |
2004-08
|
| Results First Posted: |
|
| Last Update Posted: |
2006-02-13
|
| Locations: |
Baskent University Ankara Hospital, Ankara, 06490, Turkey
|
| URL: |
https://clinicaltrials.gov/show/NCT00290394
|
